# Editas Medicine, Inc.: filings

EDIT · Nasdaq · CIK 1650664 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/edit.md) · [Financials](/companies/edit/financials.md) · [Filings](/companies/edit/filings.md) · [Insiders](/companies/edit/insiders.md)

## Reports and events: 192 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 298, 8-K 131, 3 45, SC 13G/A 36, 10-Q 32, 144 23, CT ORDER 14, 424B5 13, DEFA14A 12, S-8 12, 10-K 11, SC 13G 11, DEF 14A 10, 424B7 8, CORRESP 5, EFFECT 5, S-3ASR 5, 4/A 4, SCHEDULE 13G 4, SEC STAFF LETTER 4, ARS 3, S-3 3, SC 13D/A 3, UPLOAD 3, DRS/A 2, DRSLTR 2, SCHEDULE 13G/A 2, 10-Q/A 1, 424B1 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, D 1, DRS 1, POS AM 1, POSASR 1, PRE 14A 1, S-1 1, S-1/A 1, S-3/A 1, S-3MEF 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 07:04 ET | [8-K](/filings/0001650664-26-000093.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-26-000093 |
| 2026-08-05 | 16:05 ET | [10-Q](/filings/0001650664-26-000083.md) | Quarterly report, period 2026-06-30 | 0001650664-26-000083 |
| 2026-08-05 | 16:03 ET | [8-K](/filings/0001650664-26-000082.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001650664-26-000082 |
| 2026-06-18 | 16:28 ET | [8-K](/filings/0001650664-26-000063.md) | 5.07 Shareholder vote results | 0001650664-26-000063 |
| 2026-05-26 | 16:42 ET | [8-K](/filings/0001104659-26-066317.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-066317 |
| 2026-05-26 | 08:07 ET | [8-K](/filings/0001104659-26-066021.md) | 8.01 Other events | 0001104659-26-066021 |
| 2026-05-26 | 06:09 ET | [8-K](/filings/0001104659-26-065908.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065908 |
| 2026-05-14 | 06:16 ET | [8-K](/filings/0001650664-26-000049.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-26-000049 |
| 2026-05-05 | 16:16 ET | [10-Q](/filings/0001650664-26-000045.md) | Quarterly report, period 2026-03-31 | 0001650664-26-000045 |
| 2026-05-05 | 07:03 ET | [8-K](/filings/0001650664-26-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-26-000043 |
| 2026-04-28 | 16:34 ET | [DEF 14A](/filings/0001650664-26-000037.md) | Proxy statement, period 2026-04-28 | 0001650664-26-000037 |
| 2026-04-07 | 16:28 ET | [8-K](/filings/0001650664-26-000030.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001650664-26-000030 |
| 2026-03-27 | 07:02 ET | [8-K](/filings/0001650664-26-000027.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-26-000027 |
| 2026-03-09 | 16:50 ET | [10-K](/filings/0001650664-26-000017.md) | Annual report, period 2025-12-31 | 0001650664-26-000017 |
| 2026-03-09 | 07:02 ET | [8-K](/filings/0001650664-26-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-26-000013 |
| 2025-11-10 | 16:05 ET | [10-Q](/filings/0001650664-25-000156.md) | Quarterly report, period 2025-09-30 | 0001650664-25-000156 |
| 2025-11-10 | 07:06 ET | [8-K](/filings/0001650664-25-000153.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-25-000153 |
| 2025-10-09 | 16:31 ET | [8-K](/filings/0001650664-25-000148.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-25-000148 |
| 2025-09-02 | 07:03 ET | [8-K](/filings/0001650664-25-000134.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-25-000134 |
| 2025-08-12 | 16:08 ET | [10-Q](/filings/0001650664-25-000125.md) | Quarterly report, period 2025-06-30 | 0001650664-25-000125 |
| 2025-08-12 | 16:03 ET | [8-K](/filings/0001650664-25-000123.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-25-000123 |
| 2025-06-12 | 06:28 ET | [8-K](/filings/0001650664-25-000106.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-25-000106 |
| 2025-06-02 | 17:28 ET | [8-K](/filings/0001650664-25-000086.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001650664-25-000086 |
| 2025-05-14 | 07:06 ET | [8-K](/filings/0001650664-25-000081.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-25-000081 |
| 2025-05-13 | 07:04 ET | [8-K](/filings/0001650664-25-000077.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-25-000077 |
| 2025-05-12 | 17:05 ET | [10-Q](/filings/0001650664-25-000073.md) | Quarterly report, period 2025-03-31 | 0001650664-25-000073 |
| 2025-05-12 | 16:32 ET | [8-K](/filings/0001650664-25-000071.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-25-000071 |
| 2025-04-15 | 16:16 ET | [DEF 14A](/filings/0001650664-25-000058.md) | Proxy statement, period 2025-04-15 | 0001650664-25-000058 |
| 2025-03-20 | 16:30 ET | [8-K](/filings/0001650664-25-000031.md) | 5.02 Departure or appointment of officers or directors | 0001650664-25-000031 |
| 2025-03-05 | 16:21 ET | [10-K](/filings/0001650664-25-000022.md) | Annual report, period 2024-12-31 | 0001650664-25-000022 |
| 2025-03-05 | 16:11 ET | [8-K](/filings/0001650664-25-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-25-000020 |
| 2025-01-13 | 09:03 ET | [8-K](/filings/0001650664-25-000003.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001650664-25-000003 |
| 2024-12-17 | 16:17 ET | [8-K](/filings/0001650664-24-000144.md) | 5.02 Departure or appointment of officers or directors | 0001650664-24-000144 |
| 2024-12-12 | 16:06 ET | [8-K](/filings/0001650664-24-000141.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-24-000141 |
| 2024-12-10 | 19:32 ET | [8-K](/filings/0001650664-24-000138.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001650664-24-000138 |
| 2024-11-04 | 07:36 ET | [10-Q](/filings/0001650664-24-000121.md) | Quarterly report, period 2024-09-30 | 0001650664-24-000121 |
| 2024-11-04 | 07:33 ET | [8-K](/filings/0001650664-24-000120.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-24-000120 |
| 2024-10-22 | 07:04 ET | [8-K](/filings/0001650664-24-000114.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001650664-24-000114 |
| 2024-10-04 | 18:05 ET | [8-K](/filings/0001650664-24-000111.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001650664-24-000111 |
| 2024-08-07 | 16:11 ET | [10-Q](/filings/0001650664-24-000097.md) | Quarterly report, period 2024-06-30 | 0001650664-24-000097 |
| 2024-08-07 | 07:06 ET | [8-K](/filings/0001650664-24-000094.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-24-000094 |
| 2024-06-27 | 17:02 ET | [8-K](/filings/0001650664-24-000081.md) | 5.02 Departure or appointment of officers or directors | 0001650664-24-000081 |
| 2024-06-14 | 06:04 ET | [8-K](/filings/0001650664-24-000078.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-24-000078 |
| 2024-05-31 | 16:18 ET | [8-K](/filings/0001650664-24-000050.md) | 5.07 Shareholder vote results | 0001650664-24-000050 |
| 2024-05-08 | 16:21 ET | [10-Q](/filings/0001650664-24-000037.md) | Quarterly report, period 2024-03-31 | 0001650664-24-000037 |
| 2024-05-08 | 07:08 ET | [8-K](/filings/0001650664-24-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-24-000034 |
| 2024-04-16 | 16:25 ET | [DEF 14A](/filings/0001650664-24-000025.md) | Proxy statement, period 2024-04-16 | 0001650664-24-000025 |
| 2024-02-28 | 16:13 ET | [10-K](/filings/0001650664-24-000008.md) | Annual report, period 2023-12-31 | 0001650664-24-000008 |
| 2024-02-28 | 07:06 ET | [8-K](/filings/0001650664-24-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001650664-24-000006 |
| 2023-12-13 | 09:02 ET | [8-K](/filings/0001650664-23-000038.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001650664-23-000038 |

Page 1 of 4. [Older](/companies/edit/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.